Hyperfine, Inc. (HYPR) Stock

Hyperfine, Inc. (HYPR) is a Healthcare stock trading at $1.58 (as of 2026-06-18), with a market capitalization of $152.40M and a trailing P/E of -4.0. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Hyperfine, Inc. provides imaging, monitoring, and magnetic resonance imaging products. It offers Swoop Portable MR imaging system to address an unmet need in point-of-care medical imaging through a combination of hardware and software services. The company was incorporated in 2014 and is based in Guilford, Connecticut.

Valuation — source: SEC EDGAR (first-party)
Price$1.58
Market Cap$152.40M
P/E Ratio-4.0
EV / EBITDA-3.8
Price / Book4.55
Price / Sales10.20
DCF Value (model)$-5.62
DCF Upside vs Price-455.7%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$13.56M
Net Margin-262.3%
Return on Equity-101.2%
Debt / Equity0.38
Current Ratio5.52
Revenue Growth (YoY)5.2%
EPS Growth (YoY)-23.2%
FCF Growth (YoY)-25.6%
Financial Health — source: SEC EDGAR
Altman Z-Score-4.04 (distress)
Valuation vs Sector & Industry
Stock P/E-4.0
Sector P/E (Healthcare)21.0
Industry P/E (Medical Equipment)31.7
vs Sector-119.1%
vs Industry-112.6%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderVANGUARD CAPITAL MANAGEMENT LLC ($3.73M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryMedical Equipment
CEOMaria Degois-Sainz
Employees111
CountryUS
IPO Date2021-01-28

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

  • Lakeland Industries, Inc. (LAKE)
  • Pulmonx Corporation (LUNG)
  • Safe Pro Group Inc. Common Stock (SPAI)
  • PolyPid Ltd. (PYPD)
  • DarioHealth Corp. (DRIO)
  • InspireMD, Inc. (NSPR)
  • Prenetics Global Limited (PRE)
  • Plus Therapeutics, Inc. (PSTV)
HYPR earnings history · HYPR institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.